ny-eso-1 t cells
Cell therapyexperimental
Clinical trial activity
1 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2014 (NCT01795976)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Cancer/testis antigen 1Immunity, passive
Cancer/testis antigen 1 immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ny-eso-1 t cells
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01795976 | Phase 2 | Oct 1, 2014 | Erasmus University Rotterdam, Karolinska Institute, Netherlands Cancer Institute, The Christie NHS Foundation Trust, University of London, Vita-Salute University of Milano. Italy |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Erasmus University Rotterdam | Academic/Hospital | 1 | 0 | 1 | 2014 |
| Karolinska Institute | Academic/Hospital | 1 | 0 | 1 | 2014 |
| Netherlands Cancer Institute | Academic/Hospital | 1 | 0 | 1 | 2014 |
| The Christie NHS Foundation Trust | Academic/Hospital | 1 | 1 | 1 | 2014 |
| University of London | Academic/Hospital | 1 | 0 | 1 | 2014 |
| Vita-Salute University of Milano. Italy | Academic/Hospital | 1 | 0 | 1 | 2014 |
6 organizations
Page 1 / 1